collage of head shot of Black woman researchers wearing protective glasses and photo of potatoes Share on Pinterest
Researchers have discovered a new antibiotic with potential in treating yeast infections. Design by Medical News Today; photography by Maskot/Getty Images and Catherine McQueen/Getty Pictures.

  • After discovering the bacterium Dickeya solani more than a decade ago, researchers found a compound that could be helpful inside treating the fungus that causes infections in humans.
  • Researchers found the compound while analyzing the microbe’s genes.
  • The antiseptic compound, solanimycin, comes from a microbe found in potatoes.
  • Many of the microorganisms that will antibiotics are derived from are originally found inside soil.

In a brand new study published in mBio , scientists in Europe discovered a new antibiotic called solanimycin. Not only does solanimycin target a fungus in humans that can cause infections, but it may be beneficial for treating certain plant fungi as well.

Research is in the preliminary stages, but the particular study authors hope that further clinical studies may lead to the antibiotic becoming used both in medical and agricultural settings.

According to the Centers with regard to Disease Control and Prevention (CDC), antibiotics are usually “medicines that will fight bacterial infections caused by bacteria in humans and animals by either killing the bacteria or making it difficult for the germs to grow and multiply. ”

By slowing down bacterias growth in the body with antibiotics, it becomes easier for that body’s immune system in order to attack the particular infection. While antibiotics are helpful along with treating infections caused simply by bacteria or even a fungus, they are usually not used to treat viruses.

Some remedies that are prescribed often include azithromycin , amoxicillin , penicillin , plus cephalexin .

Inside addition to traditional antibiotics, there is another class known as antifungal antibiotics, which target fungi. The National Library of Medicine notes that “[f]ungi are usually unicellular or multicellular eukaryotic organisms that will exist in all environments worldwide. ”

While there are millions associated with types of fungus, according to the CDC only a few hundred have a negative impact on humans. Some common fungal diseases include nail infections, eye infections, pneumocystis pneumonia, and vaginal candidiasis .

Typically fungal diseases are simple in order to treat, but occasionally they lead to more serious issues such as asthma , lung infections, plus meningitis .

As Dr . Tom Chiller comments in The Fungus Among Us podcast, “[t]here are fungal diseases that can be invasive — in other words, they can get into our bodies possibly via the lung or via some other route and can get into our bloodstream, get into our organs, and really cause serious damage. ”

Doctor Chiller is the chief of the Mycotic Diseases Branch from the CDC.

Just because an antibiotic is useful in treating bacteria or even fungi does not mean it will be useful forever, as these pathogens can mutate and become resistant over time. This is the basis for your research that led to the study of solanimycin.

“The increasing emergence of drug-resistant fungal bacterial infections has necessitated a search for new compounds capable of combating fungal pathogens of plants, animals, plus humans, ” write the study writers.

Researchers first discovered the bacteria Dickeya solani on tomatoes in 2005–2006. Subsequent study showed that it is more commonly present in potato plants.

The bacterium causes disease in vegetation that may slow down plant growth or even kill them, so this can be a major threat in order to crops.

While initially researching D. solani , scientists learned that particular gene clusters produce a good antibiotic called oocydin A.

The researchers continued studying D. solani over the years and noticed some changes. The authors noted that some mutations lost some properties, “but still retained strong activity against several plant-pathogenic fungi. ”

Based on that realization, the experts suspected that they might be able to find an additional antibiotic. After studying the particular D. solani genome, these people discovered the antifungal antiseptic they named solanimycin.

The particular study authors were primarily interested inside how solanimycin works against plant fungus and discovered that it was “active towards around 70%” of the particular plant fungi they tested.

Additionally , they will learned that solanimycin is effective within treating Candida albicans .

Candida is found both inside people’s bodies and on their skin. Whenever there is an overgrowth, this may lead to infections.

The most common Yeast infection infections include urinary bacterial infections, genital infections, and oral thrush . Based on the CDC , Candida fungus can also cause the lung infection Valley fever , and histoplasmosis .

Whilst you will find antifungal antibiotics available, solanimycin could potentially add to the tools available to treat bacterial infections.

While most people with infections brought on by Yeast should recover without issue, some people have more difficulty with these infections. People with weakened immune systems are at a higher risk regarding infections in general and have a more difficult time fighting them off.

People with cancer or HIV or people who take medications that will lower the immune system can develop life-threatening illnesses stemming through these bacterial infections and can benefit from the discovery of a new antibiotic.

“We have to be open to the exploration of everything that’s out there in order to find new antibiotics, ” says study co-author Dr . Miguel Matilla .

Doctor Matilla is a molecular microbiologist at Zaidín Experimental Station in Granada, Spain.

“Fungal infections represent a major clinical, farming, and food security threat worldwide, which is accentuated due to the difficult treatment of these bacterial infections, ” write the writers.

Dr. Paul Peak spoke to Healthcare News Nowadays about the particular discovery associated with solanimycin.

“Overall, it’s encouraging to read the research done involving the particular novel antifungal, solanimycin, ” commented Dr. Peak. “Even though it’s too early to know the clinical impact, the fact that solanimycin was active against Candida albicans — the most common source of fungal infections in people — will be a positive sign. ”

Dr . Peak is the vice president of the particular Clinical Pharmacy program intended for Sedgwick, the healthcare claims company based in Memphis, TN.

Doctor Peak went on to elaborate on the importance of continuing such analysis:

“The fact that this discovery originated in a pathogen that impacts taters may mean that there are other similar discoveries waiting to become found. ”

“A lot associated with focus on drug resistance has historically been centered around antibiotics, so it is usually good in order to see that will science is also discovering new potential treatments for yeast infections. Hopefully, this will bring more attention to the particular fact that antifungal resistance is an increasing threat as well, ” he added.

Leave a Reply

Your email address will not be published. Required fields are marked *